Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 27, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $15.05 | 163,204 | |
| Jul 27, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 30,000 | |
| Jul 29, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Aug 03, 2020 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 10,000 | $6.06 | 348,764 | |
| Aug 03, 2020 | Director, Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 10,000 | $14.78 | 338,764 | |
| Aug 03, 2020 | Director, Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 10,000 | -- | -- | |
| Aug 03, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | $5.96 | 900,368 | |
| Aug 03, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 39,655 | $14.78 | 860,713 | |
| Aug 03, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | -- | 63,975 | |
| Aug 03, 2020 | Director | Open market or private purchase of non-derivative or derivative security | Form 4 | 1,500 | $14.53 | 32,467 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.